Delivery Order SPE2DR25D1021-SPE2DR26FNL1D
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $66,148.76 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication indicated for weight management, reflecting the agency's procurement needs for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,103.40 for Zepbound 7.5 mg/0.5 mL pens on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. Zepbound is a semaglutide-based medication indicated for weight management and represents part of the pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,262.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based pharmaceutical product used for weight...
- The Defense Logistics Agency awarded a $13,859.30 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $13,306.04 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a semaglutide injection used for weight management in adults with obesity or...
- The Defense Logistics Agency awarded a $3,431.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This non-competitive delivery order was issued under an existing contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist indicated for weight management, reflecting the...
- The Defense Logistics Agency awarded a $16,675.15 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price contract, which was not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $2,594.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with an ultimate completion date of September 5, 2025. Zepbound is a semaglutide-based medication indicated for weight management and diabetes treatment. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery...
- The Defense Logistics Agency awarded a $47,062.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 15 mg/0.5 mL pens valued at $3,812.98. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. Zepbound is a semaglutide-based medication used for weight...